- A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer. Adjei, A.A., Reid, J.M., Erlichman, C., Sloan, J.A., Pitot, H.C., Alberts, S.R., Goldberg, R.M., Hanson, L.J., Ruben, S., Boemer, S.A., Atherton, P., Ames, M.M., Kaufmann, S.H. Investigational new drugs. (2002)